Rankings
▼
Calendar
KIDS (OrthoPediatrics Corp.) Stock Financials & Earnings | Market Cap Arena
KIDS
OrthoPediatrics Corp.
Mkt Cap
$469M
Healthcare
·
Medical - Devices
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$236M
Net Income (TTM)
-$40M
EPS (TTM)
-$1.69
Free Cash Flow (TTM)
-$16M
Gross Margin
73.1%
Op. Margin
-12.3%
Net Margin
-16.8%
FCF Margin
-6.8%
P/S Ratio (TTM)
2.0x
P/E Ratio (TTM)
—
YoY Rev Growth
+15.4%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$32M
$24M
-$9M
Q2 23
$40M
$30M
-$6M
Q3 23
$40M
$31M
-$5M
Q4 23
$38M
$27M
-$8M
Q1 24
$45M
$32M
-$10M
Q2 24
$53M
$41M
-$6M
Q3 24
$55M
$40M
-$6M
Q4 24
$53M
$36M
-$14M
Q1 25
$52M
$38M
-$11M
Q2 25
$61M
$44M
-$11M
Q3 25
$61M
$45M
-$5M
Q4 25
$62M
$45M
-$2M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
3.6x
132.1x
Q2 23
3.4x
470.2x
Q3 23
3.3x
—
Q4 23
3.2x
—
Q1 24
2.9x
—
Q2 24
2.7x
—
Q3 24
2.5x
—
Q4 24
2.3x
—
Q1 25
2.2x
—
Q2 25
2.1x
—
Q3 25
2.1x
—
Q4 25
2.0x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$6M
-$11M
Q2 23
-$4M
-$10M
Q3 23
-$9M
-$11M
Q4 23
-$8M
-$13M
Q1 24
-$7M
-$13M
Q2 24
-$6M
-$13M
Q3 24
-$10M
-$12M
Q4 24
-$4M
-$4M
Q1 25
-$4M
-$8M
Q2 25
-$10M
-$14M
Q3 25
-$581K
-$3M
Q4 25
$10M
$10M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$5M
Q2 23
$6M
Q3 23
$2M
Q4 23
$6M
Q1 24
$6M
Q2 24
$7M
Q3 24
$1M
Q4 24
$262K
Q1 25
$4M
Q2 25
$3M
Q3 25
$3M
Q4 25
$599K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+34.9%
+34.8%
Q2 23
+20.1%
+23.1%
Q3 23
+14.4%
+16.1%
Q4 23
+21.4%
+16.2%
Q1 24
+41.5%
+35.4%
Q2 24
+33.5%
+29.5%
Q3 24
+36.5%
+35.2%
Q4 24
+40.0%
+46.1%
Q1 25
+17.3%
+16.5%
Q2 25
+15.7%
+22.7%
Q3 25
+12.2%
+9.9%
Q4 25
+17.0%
-3.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$2M
6.7%
Q2 23
$3M
8.3%
Q3 23
$2M
5.9%
Q4 23
$3M
7.3%
Q1 24
$3M
6.3%
Q2 24
$3M
5.6%
Q3 24
$4M
7.2%
Q4 24
$4M
7.4%
Q1 25
$4M
7.4%
Q2 25
$5M
8.6%
Q3 25
$4M
6.9%
Q4 25
$4M
7.2%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$2M
$18M
$12M
Q2 23
$3M
$19M
$14M
Q3 23
$3M
$18M
$14M
Q4 23
$3M
$20M
$12M
Q1 24
$3M
$25M
$14M
Q2 24
$3M
$27M
$17M
Q3 24
$3M
$26M
$17M
Q4 24
$3M
$24M
$17M
Q1 25
$2M
$30M
$17M
Q2 25
$2M
$30M
$19M
Q3 25
$2M
$29M
$19M
Q4 25
$2M
$30M
$18M
marketcaparena.com
Revenue Segments
Spine
Sports Medicine And Other
Trauma And Deformity
Quarter
Spine
Sports Medicine And Other
Trauma And Deformity
Q1 23
$7M
$1M
$23M
Q2 23
$11M
$1M
$28M
Q3 23
$10M
$862K
$29M
Q1 24
$10M
$1M
$33M
Q2 24
$14M
$1M
$38M
Q3 24
$16M
$1M
$38M
Q1 25
$14M
$880K
$38M
Q2 25
$19M
$905K
$42M
Q3 25
$16M
$846K
$44M
marketcaparena.com
Revenue by Geography
Non-US
United States
Quarter
Non-US
United States
Q1 23
$8M
$24M
Q2 23
$10M
$30M
Q3 23
$11M
$29M
Q4 23
$9M
$28M
Q1 24
$10M
$34M
Q2 24
$12M
$41M
Q3 24
$12M
$43M
Q1 25
$12M
$41M
Q2 25
$13M
$48M
Q3 25
$13M
$49M
Q4 25
$13M
$49M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$35M
$73M
$108M
Q2 23
$10M
$83M
$93M
Q3 23
$11M
$72M
$82M
Q4 23
$31M
$49M
$80M
Q1 24
$22M
$26M
$48M
Q2 24
$29M
$0
$29M
Q3 24
$51M
$25M
$76M
Q4 24
$44M
$25M
$69M
Q1 25
$33M
$25M
$59M
Q2 25
$45M
$26M
$70M
Q3 25
$17M
$41M
$58M
Q4 25
$20M
$41M
$61M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
23M
+0.1%
Q2 23
23M
+0.9%
Q3 23
23M
+0.3%
Q4 23
23M
-0.0%
Q1 24
23M
+0.3%
Q2 24
23M
+1.4%
Q3 24
23M
+0.1%
Q4 24
23M
+0.0%
Q1 25
23M
+0.3%
Q2 25
23M
+0.5%
Q3 25
23M
+0.3%
Q4 25
24M
+0.7%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
—
—
FY 15
—
—
FY 16
—
—
FY 17
$661K
69
FY 18
$719K
80
FY 19
$772K
94
FY 20
$613K
116
FY 21
$737K
133
FY 22
$602K
203
FY 23
$602K
247
FY 24
$364K
562
FY 25
$30K
8K
marketcaparena.com